Tag: Rajiv Malik
DCGI’s green signal to Mylan’s launch of Avonza in India
The new drug by Mylan offers an innovative, reduced-dose alternative first-line regimen for people being treated for HIV/AIDS in India.........
USFDA accepts Mylan & Biocon’s proposed biosimilar Pegfilgrastim for review
The development marks the second successful biologics license application (BLA) for filing of the partnership in the United States of America...